Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.

NCT01699685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease: COPD

Interventions

DRUG: QAB149
DRUG: Placebo
DRUG: NVA237

Sponsor

Novartis Pharmaceuticals